Actos: Is Two Better Than One?
At the end of September, I reported on a "new" drug from Actos maker Takeda pharmaceutical, which is currently marketed outside the U.S. as Nesina. It is not actually new; it is a combination of Actos and another anti-diabetic drug, alogliptin. which was submitted to the FDA for approval in late 2007, but withdrawn the following year after the FDA determined that additional data was needed.